- Home
- NDRA vs VNRX Comparison
NDRA vs VNRX Comparison
Compare NDRA & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NDRA | VNRX |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2M | 7.2M |
| IPO Year | 2016 | 2012 |
Fundamental Metrics
Financial Performance| Metric | NDRA | VNRX |
|---|---|---|
| Price | $4.97 | $0.18 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $13.62 |
| AVG Volume (30 Days) | 25.1K | ★ 1.9M |
| Earning Date | 11-16-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 84.32 | 38.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,727,384.00 |
| Revenue This Year | N/A | $57.67 |
| Revenue Next Year | N/A | $240.52 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 40.04 |
| 52 Week Low | $2.96 | $0.13 |
| 52 Week High | $6.95 | $3.26 |
Technical Indicators
Market Signals| Indicator | NDRA | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 39.60 | 24.66 |
| Support Level | $4.87 | $0.15 |
| Resistance Level | $4.90 | $0.18 |
| Average True Range (ATR) | 0.36 | 0.02 |
| MACD | -0.16 | 0.01 |
| Stochastic Oscillator | 9.73 | 8.57 |
Price Performance
Historical ComparisonAbout NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.